These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7074655)

  • 1. Role of radiation therapy in the treatment of Hodgkin's disease.
    Hellman S; Mauch P
    Cancer Treat Rep; 1982 Apr; 66(4):915-23. PubMed ID: 7074655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease.
    Mauch P; Gorshein D; Cunningham J; Hellman S
    Cancer Treat Rep; 1982 Apr; 66(4):809-17. PubMed ID: 7074652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
    Yildiz F; Zengin N; Engin H; Güllü I; Barista I; Caglar M; Ozyar E; Cengiz M; Gürkaynak M; Zorlu F; Caner B; Atahan IL; Tekuzman G
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):839-46. PubMed ID: 15465201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of stage IIIA Hodgkin's disease.
    Neely SM; Golomb HM
    Cancer Treat Rep; 1982 Apr; 66(4):827-34. PubMed ID: 7074654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative study.
    Stein RS; Golomb HM; Wiernik PH; Mauch P; Hellman S; Ultmann JE; Rosenthal DS; Flexner JM
    Cancer Treat Rep; 1982 Apr; 66(4):733-41. PubMed ID: 7074643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of care outcome studies in Hodgkin's disease: results of the national practice and implications for management.
    Hanks GE; Kinzie JJ; Herring DF; Kramer S
    Cancer Treat Rep; 1982 Apr; 66(4):805-8. PubMed ID: 7074651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease in a community oncology center: ten years' experience.
    Beck TM; Montgomery P; Smith CE
    West J Med; 1982 May; 136(5):384-9. PubMed ID: 7101905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
    J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
    J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hodgkin's disease in stages I and IIA. Analysis of results in a group of patients with a follow-up of at least 10 years treated at the onset of the disease with radiotherapy alone].
    Maurizi Enrici R; Falchetto Osti M; Anselmo AP; Tombolini V; Cartoni C; Scattoni Padovan F; Sbarbati S; Cavaceppi P; Biagini C
    Radiol Med; 1995 Jun; 89(6):855-60. PubMed ID: 7644742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease.
    Shahidi M; Kamangari N; Ashley S; Cunningham D; Horwich A
    Radiother Oncol; 2006 Jan; 78(1):1-5. PubMed ID: 16309770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
    J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.